At ICE Bioscience, we provide reporter gene assay services for studying gene expression, pathway activity, and cellular regulation. By linking a reporter gene to a regulatory sequence of interest, reporter gene activity can be measured as a functional readout of the associated target pathway.

A diverse range of cell lines is available for stable or transient transfection formats.
Reporter constructs support pathway studies including AP-1, NF-κB, CRE, and ARE signaling.
GPCR signaling studies ↗ support the discovery of drugs for metabolic disorders and other therapeutic areas.
Cytokine activity and immune responses can be measured to support immunotherapy and anti-inflammatory drug development.
Nuclear receptor research ↗ uses custom cell lines to investigate hormone-related disease biology.
DDR assays ↗, including HR and NHEJ reporter systems, support cancer biology and oncology therapeutic research.
Reporter systems can support high-throughput screening for the rapid identification of therapeutic compounds.
Customized reporter gene assays can be developed according to specific research requirements.

Facilitates the identification and validation of new drug targets.
Helps elucidate mechanisms of gene regulation in response to different stimuli.
Provides insights into complex cellular signaling pathways.
Supports cytotoxicity assessment during drug development.
Supports fundamental biological and disease-oriented research.
ICE Bioscience provides reliable, high-quality reporter gene assay services to support research and development programs.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top